23 agosto 2010
Yondelis , estado actual de la Fase III para Tratamiento de Primera Linea en Pacientes con Translocation-Related Sarcomas (TRS) .
Current Study:
ClinicalTrials.gov Id: NCT00796120
Study Title: A Study of the Safety and Effectiveness of Trabetedin Versus Doxorubicin-based Chemotherapy in Patients With Translocation-Related Sarcomas (TRS)
First Received: November 20, 2008
Last Updated: August 19, 2010
Suscribirse a:
Entradas (Atom)